Literature DB >> 17597401

The activity of RhoA is correlated with lymph node metastasis in human colorectal cancer.

Yoji Takami1, Morihiro Higashi, Shinpei Kumagai, Paul C Kuo, Hidetada Kawana, Keiji Koda, Masaru Miyazaki, Kenichi Harigaya.   

Abstract

Rho family GTPases play a pivotal role in the regulation of numerous cellular functions associated with malignant transformation and metastasis. To evaluate the role of these GTPases in colorectal cancer, the protein expression levels and activities of these proteins in matched sets of tumor and non-tumor tissues of surgical specimens were analyzed. The relationship between the protein levels and activities in tumor tissues to the clinicopathological features was also assessed. The expression levels of RhoA, active RhoA, Rac1, and active Rac1 in tumor tissues were higher than in normal tissues. The amounts of active RhoA protein in primary tumors correlated with lymph nodes metastasis. No relationship was noted between the protein expression levels and other clinicopathological findings. These findings suggest that the Rho family small GTPases are related to malignant transformation and progression of colorectal cancer and the activation of RhoA is associated with the lymph node metastasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17597401     DOI: 10.1007/s10620-007-9887-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  15 in total

1.  Accumulation of GTP-bound RhoA during cytokinesis and a critical role of ECT2 in this accumulation.

Authors:  K Kimura; T Tsuji; Y Takada; T Miki; S Narumiya
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

Review 2.  Rho GTPases and the actin cytoskeleton.

Authors:  A Hall
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

3.  Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways.

Authors:  B Bouzahzah; C Albanese; F Ahmed; F Pixley; M P Lisanti; J D Segall; J Condeelis; D Joyce; A Minden; C J Der; A Chan; M Symons; R G Pestell
Journal:  Mol Med       Date:  2001-12       Impact factor: 6.354

4.  Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b.

Authors:  A Schnelzer; D Prechtel; U Knaus; K Dehne; M Gerhard; H Graeff; N Harbeck; M Schmitt; E Lengyel
Journal:  Oncogene       Date:  2000-06-15       Impact factor: 9.867

5.  Rho GTPases are over-expressed in human tumors.

Authors:  G Fritz; I Just; B Kaina
Journal:  Int J Cancer       Date:  1999-05-31       Impact factor: 7.396

6.  Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer.

Authors:  Takao Kamai; Toshihiko Tsujii; Kyoko Arai; Kentaro Takagi; Hidekazu Asami; Yuji Ito; Hiroyuki Oshima
Journal:  Clin Cancer Res       Date:  2003-07       Impact factor: 12.531

7.  Evaluation of echographic diagnosis of rectal cancer using intrarectal ultrasonic examination.

Authors:  N Saitoh; K Okui; H Sarashina; M Suzuki; T Arai; M Nunomura
Journal:  Dis Colon Rectum       Date:  1986-04       Impact factor: 4.585

8.  Magnetic resonance imaging of rectal carcinoma: a prospective study.

Authors:  M M McNicholas; W P Joyce; J Dolan; R G Gibney; D P MacErlaine; J Hyland
Journal:  Br J Surg       Date:  1994-06       Impact factor: 6.939

9.  Preoperative assessment of mesorectal lymph node involvement in rectal cancer.

Authors:  J Beynon; N J Mortensen; D M Foy; J L Channer; H Rigby; J Virjee
Journal:  Br J Surg       Date:  1989-03       Impact factor: 6.939

10.  Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas.

Authors:  H Suwa; G Ohshio; T Imamura; G Watanabe; S Arii; M Imamura; S Narumiya; H Hiai; M Fukumoto
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

View more
  15 in total

1.  Chemotherapy Resistance in Diffuse-Type Gastric Adenocarcinoma Is Mediated by RhoA Activation in Cancer Stem-Like Cells.

Authors:  Changhwan Yoon; Soo-Jeong Cho; Bülent Arman Aksoy; Do Joong Park; Nikolaus Schultz; Sandra W Ryeom; Sam S Yoon
Journal:  Clin Cancer Res       Date:  2015-10-19       Impact factor: 12.531

2.  Expression of deleted in liver cancer 2 in colorectal cancer and its correlation with clinicopathological parameters.

Authors:  Kai Gao; Xiaorong Li; Gui Hu; Kaiyan Yang; Buning Tian; Yi Zhang
Journal:  Oncol Lett       Date:  2012-08-06       Impact factor: 2.967

3.  The Correlation Between RhoA Expression and Clinicopathological Characteristics in Gastric Cancer Patients After Curative Surgery.

Authors:  Kuo-Hung Huang; Yuan-Tzu Lan; Ming-Huang Chen; Yee Chao; Su-Shun Lo; Anna Fen-Yau Li; Chew-Wun Wu; Shih-Hwa Chiou; Muh-Hwa Yang; Yi-Ming Shyr; Wen-Liang Fang
Journal:  World J Surg       Date:  2015-09       Impact factor: 3.352

4.  TrkBT1 induces liver metastasis of pancreatic cancer cells by sequestering Rho GDP dissociation inhibitor and promoting RhoA activation.

Authors:  Zhongkui Li; Zhe Chang; Lucia J Chiao; Ya'an Kang; Qianghua Xia; Cihui Zhu; Jason B Fleming; Douglas B Evans; Paul J Chiao
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

5.  New specific molecular targets for radio-chemotherapy of rectal cancer.

Authors:  Kristin Snipstad; Christopher G Fenton; Jørn Kjaeve; Guanglin Cui; Endre Anderssen; Ruth H Paulssen
Journal:  Mol Oncol       Date:  2009-11-25       Impact factor: 6.603

6.  Silencing of RhoA and RhoC expression by RNA interference suppresses human colorectal carcinoma growth in vivo.

Authors:  Haibo Wang; Gang Zhao; Xiangping Liu; Aihua Sui; Kun Yang; Ruyong Yao; Zongbao Wang; Qiang Shi
Journal:  J Exp Clin Cancer Res       Date:  2010-09-09

Review 7.  [Value of targeted treatment for testicular cancer: from molecular approaches to clinical possibilities].

Authors:  A Martinschek; C G Ruf; C Sparwasser; H U Schmelz
Journal:  Urologe A       Date:  2008-10       Impact factor: 0.639

8.  Increased RhoA Activity Predicts Worse Overall Survival in Patients Undergoing Surgical Resection for Lauren Diffuse-Type Gastric Adenocarcinoma.

Authors:  Kevin K Chang; Soo-Jeong Cho; Changhwan Yoon; Jun Ho Lee; Do Joong Park; Sam S Yoon
Journal:  Ann Surg Oncol       Date:  2016-06-30       Impact factor: 5.344

9.  Effect of shRNA targeted against RhoA on proliferation and migration of human colonic cancer cells.

Authors:  Man Wang; Xiu-Jie Wang; Bing-Rong Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

10.  Systems biology approach to identification of biomarkers for metastatic progression in cancer.

Authors:  Andrey A Ptitsyn; Michael M Weil; Douglas H Thamm
Journal:  BMC Bioinformatics       Date:  2008-08-12       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.